Pulmonary Endoscopy Devices Market - Global Forecast 2025-2032

The pulmonary endoscopy devices market is experiencing significant transformation as healthcare providers innovate to meet changing technological, procurement, and regulatory challenges. This landscape requires decisive leadership to implement responsive strategies and sustain clinical efficiency.

Pulmonary Endoscopy Devices Market Snapshot

In 2024, the global pulmonary endoscopy devices market reached a valuation of USD 6.83 billion and is advancing at a compound annual growth rate (CAGR) of 6.94%. Projections indicate continued growth, with revenue expected to reach USD 7.30 billion by 2025 and USD 11.69 billion by 2032. Key growth catalysts include the integration of advanced imaging solutions and expanded use of compact, miniaturized devices. This wave of product innovation is prompting increased investment and enabling providers to enhance respiratory procedures, update clinical workflow systems, and address more rigorous regulatory standards. The adoption of next-generation endoscopic platforms positions organizations for stronger competitiveness and resilient operations within pulmonary care.

Pulmonary Endoscopy Devices Market: Scope & Segmentation

• Product Types: Capsule endoscopes, flexible and rigid scopes, and single-use devices support procedural versatility and high infection control across various care environments.
• Applications: Used in bronchoscopy, endobronchial ultrasound, mediastinoscopy, and pleuroscopy, these devices enable diagnostic precision and minimally invasive respiratory interventions.
• End Users: Hospitals, ambulatory surgery centers, and specialty clinics deploy these solutions to streamline operational efficiency and raise clinical care standards.
• Technologies: Fiber optic and video-based endoscopy, including HD and 4K models, play a pivotal role in achieving detailed visualization and supporting advanced respiratory care delivery.
• Materials: Disposable and reusable device options offer procurement flexibility, assisting hospitals in managing hygiene standards and aligning with sustainability objectives.
• Distribution Channels: Devices are sourced via offline retailers, direct manufacturer agreements, distributor partnerships, and a growing array of digital procurement platforms, all reinforcing supply chain stability.
• Regional Coverage: Local adoption and regulatory landscapes differ across North America, South America, Europe, Middle East & Africa, and Asia-Pacific, requiring tailored strategic and compliance planning.
• Major Companies Profiled: Market participants include Olympus Corporation, Fujifilm Holdings Corporation, KARL STORZ SE & Co. KG, Hoya Corporation, Ambu A/S, Richard Wolf GmbH, Boston Scientific Corporation, Stryker Corporation, Medtronic plc, and CONMED Corporation.

Pulmonary Endoscopy Devices Market: Key Takeaways

• Cross-compatible platforms facilitate integration with electronic health records and hospital IT systems, enabling digitization and centralized device management.
• Advances in minimally invasive technologies improve patient outcomes and increase procedural efficiency across different care settings.
• Collaboration between device manufacturers and health IT companies accelerates automation and the adoption of data-driven workflows in pulmonary care.
• Procurement leaders are adopting agile sourcing strategies to navigate compliance changes, manage disruption, and ensure continuity in device availability.
• Growing demand for infection prevention is driving the transition to single-use and compact device formats, aligning with hospital hygiene protocols.
• Continuous innovation in device design supports adaptation to updated clinical guidelines and competitive market positioning.

Pulmonary Endoscopy Devices Market: Navigating Tariff Impact

Changes in U.S. trade policy have increased the import cost of pulmonary endoscopy devices. Healthcare providers are responding by diversifying sourcing approaches and seeking regionally based manufacturers to safeguard supply continuity and reduce vulnerability to further trade disruptions.

Methodology & Data Sources

This analysis is grounded in secondary research, industry regulatory reviews, and targeted interviews with pulmonologists, biomedical engineers, and procurement professionals. The structured use of Porter’s Five Forces and value chain mapping provides senior decision-makers with practical guidance for technology evaluation and vendor selection.

Why This Report Matters

• Equips senior executives to make informed decisions around technology adoption, procurement, and long-term planning in a highly regulated and evolving industry.
• Delivers actionable segmentation and regional analysis that supports compliance with local regulations and responsiveness to dynamic clinical needs.
• Prepares organizations to anticipate supply risks and maintain operational stability, especially amid fluctuating international trade environments.

Conclusion

Proactive adaptation to advances in pulmonary endoscopy and regulatory frameworks helps organizations deliver effective respiratory care while maintaining operational strength and market resilience.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.